JAK2 and cancer: Interestingly, a recent study indicated that the activation of the JAK2/STAT3 signaling pathway plays an important role in cancer cachexia [23], and the use of AG490, a JAK2 specific inhibitor, can improve the prognosis of cancer cachexia [24].